Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
Axis-Shield resists new Alere takeover attempt

UK-based diagnostics company Axis-Shield has urged shareholders to resist a fresh takeover attempt by US rival Alere.

In a statement today, Alere repeated its offer to Axis-Shield’s shareholders of 460 pence per share, which was formally made on 5 August. The offer, rejected by the Axis-Shield board, values the business at £230 million.

Alere announced today that it is lowering the threshold of its bid, which had been set at 90% of shareholder acceptance. The company said it now required more than 50% of voting rights, giving it the option of becoming a majority shareholder in Axis-Shield.

The US company also warned that if its offer were to lapse by a deadline of 10 October, “there is a strong possibility that Axis-Shield's share price would fall significantly below its current share price, particularly as no other potential bidder has announced its interest publicly”.

Alere said it was also looking at “alternative acquisitions, particularly in light of current valuations and market conditions”, and that it didn’t necessarily have to acquire Axis-Shield in order to achieve its “strategic objectives”.

In response, Axis-Shield’s board said it was “disappointed” that Alere had not taken notice of the “firm rebuttal” from shareholders to its offer, which it said was clear by the less than 1% level of acceptances that was disclosed in an Alere announcement on 16 September.

“The board has been more than willing to engage with Alere if Alere were to put a proposal to the board that fairly reflected the fundamental value of Axis-Shield. To date, no such proposal has been received from Alere,” said an Axis-Shield statement.

“The company has made excellent progress in the first half of the year and is on track to deliver for the second half of the year. The company believes that Alere is making a highly opportunistic offer in order to try and acquire Axis-Shield on the cheap.”

The 460 pence per share offer price represents a premium of 37% on the closing share price of 335 pence on 5 July 2011 – the last business day before Alere revealed it was considering an approach.
 

Posted on: 26/09/2011

Latest news stories

17/01/2019
Core Assets Group and Partnerships in Children’s Services are joining forces to create a UK specialist fostering network.
17/01/2019
Waterland Private Equity has acquired Sandcastle Care, a residential childcare provider offering long-term therapeutic care across 18 sites in the Northwest of England.
17/01/2019
Healthcare facilities investor Octopus Healthcare, part of the Octopus Group, has raised a further £133.5 million for its Octopus Healthcare Fund.
16/01/2019
Private equity firm Apposite Capital, has announced that its portfolio company Swanton Care and Community has acquired Courtyard Care.
15/01/2019
Manual, an online platform designed to improve men’s health, has achieved £5 million in venture capital seed funding .


Civica


HealthInvestor blog
The government urgently needs to bring clarity to the future of social care provision

Click here to view the HealthInvestor blog


There has been a policy-driven move towards returning responsibility for healthcare to the individual; while greater independence, choice and control over their care sounds like a positive move, for care providers, this can come with inherent risk. Clare Connell and Ryan Perrott ask, ‘Is the concept of individual choice being pushed too far?’
A recent Freedom of Information request has put local authority care home spending in question. Is it time to call public sector provision to account? HealthInvestor UK investigates
In an innovative move designed to speed up access to treatment, health insurer Bupa is joining forces with independent hospital provider HCA Healthcare UK to launch a network of specialist centres for the diagnosis and treatment of breast cancer
A CMA investigation into the CareTech-Cambian tie-up is expected to delay the deal until at least the new year. The intervention – which is one of many in the sector – also raises further questions over the potential for consolidation in sensitive areas of social care. Jeremy Bowden investigates

Click here to search all feature articles



Specialist care

Andrew Cannon, chief executive of Voyage Care, believes in understanding his workforce. The boss of the UK specialist care provider, which supports more than 3,500 people with learning disabilities, autism, brain injuries and other complex needs, says: "it's about love". HealthInvestor UK gets the lowdown
Read more


Christie + Co

my images



Recruitment and retention

When people are one of your greatest assets, it's essential that you are recruiting and retaining the right ones. Neil Eastwood, author of Saving Social Care, advisor to the Department of Health & Social Care's national recruitment campaign, and founder of Sticky People, shares his sector insight
Read more